Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
![[18F]-RoSMA-18-d6 in Amyotrophic Lateral Sclerosis: NCT05880563 Clinical Landscape Report 2026](https://synapse-static.patsnap.com/strapi-static/Blog_cover_14_36b6ffee12.jpg)
9 min read
[18F]-RoSMA-18-d6 in Amyotrophic Lateral Sclerosis: NCT05880563 Clinical Landscape Report 2026
15 October 2026
NCT05880563 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
MaaT-033 in Amyotrophic Lateral Sclerosis: NCT05889572 Clinical Landscape Report 2026
15 October 2026
NCT05889572 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tazbentetol in Amyotrophic Lateral Sclerosis: NCT05882695 Clinical Landscape Report 2026
15 October 2026
NCT05882695 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
PMG-1015 in Idiopathic Pulmonary Fibrosis: NCT05895565 Clinical Landscape Report 2026
15 October 2026
NCT05895565 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
RAG-17 in Amyotrophic Lateral Sclerosis: NCT05903690 Clinical Landscape Report 2026
15 October 2026
NCT05903690 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Fostamatinib Disodium in Sickle Cell Trait: NCT05904093 Clinical Landscape Report 2026
15 October 2026
NCT05904093 clinical landscape for Sickle Cell Trait: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
AD-214 in Idiopathic Pulmonary Fibrosis: NCT05914909 Clinical Landscape Report 2026
15 October 2026
NCT05914909 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Amifampridine phosphate in Myasthenia Gravis: NCT05919407 Clinical Landscape Report 2026
15 October 2026
NCT05919407 clinical landscape for Myasthenia Gravis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Rentosertib in Idiopathic Pulmonary Fibrosis: NCT05938920 Clinical Landscape Report 2026
15 October 2026
NCT05938920 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Diosmin in Metabolic Dysfunction Associated Steatohepatitis: NCT05942547 Clinical Landscape Report 2026
15 October 2026
NCT05942547 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
INI-822 in Metabolic Dysfunction Associated Steatohepatitis: NCT05945537 Clinical Landscape Report 2026
15 October 2026
NCT05945537 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
ARO-SOD1 in Amyotrophic Lateral Sclerosis: NCT05949294 Clinical Landscape Report 2026
15 October 2026
NCT05949294 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.